Valuation — not yet established
No valuation for Ginkgo Bioworks is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.1B) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Ginkgo Bioworks
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2021 | PIPE | $775.0M | ▮ | ▮ |
| May 2020 | Later Stage VC (Series F) | $70.0M | ▮ | ▮ |
| Sep 2019 | Later Stage VC (Series E) | $290.0M | ▮ | ▮ |
| Jul 2015 | Later Stage VC | $51.6M | ▮ | ▮ |
How Ginkgo Bioworks's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ginkgo Bioworks, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Ginkgo Bioworks raised?
- Ginkgo Bioworks has raised $1.1B in total funding across 4 recorded rounds.
- When did Ginkgo Bioworks last raise?
- Ginkgo Bioworks last raised in Sep 2021 (PIPE), raising $775.0M.